Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Debate Pro: Always

Presentation TCT 2024

Debate Pro: Always

Presenter: Marco Valgimigli

October 30, 2024

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Presentation TCT 2024

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Presenter: Marco Valgimigli

October 28, 2024

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Presentation TCT 2024

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Presenter: Marco Valgimigli

October 28, 2024

Real-Time Catheter-Based MVO Detection in STEMI: Final Results from the MOCA I Study

Presentation TCT 2024

Real-Time Catheter-Based MVO Detection in STEMI: Final Results from the MOCA I Study

Presenter: Marco Valgimigli

October 27, 2024

TCT 667: Real-Time Catheter-Based MVO Detection in STEMI: Final Results From the MOCA I Study

Presentation TCT 2024

TCT 667: Real-Time Catheter-Based MVO Detection in STEMI: Final Results From the MOCA I Study

Presenter: Marco Valgimigli

October 27, 2024

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

Presentation TCT 2024

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

Presenter: Marco Valgimigli

October 27, 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

September 01, 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.